Analysis:
To judge whether CI’s closing price will rise by February 28, the most useful fresh information is anything that could materially move the share price during the next eleven days. Key items include: 1) the company’s just-released or upcoming Q4 2025 earnings and 2026 guidance (usually reported in early February); 2) analyst upgrades/downgrades or price-target changes following those results; 3) any merger, acquisition, or divestiture developments (e.g., past speculation about Medicare Advantage or Evernorth assets); 4) regulatory or legislative actions affecting pharmacy-benefit managers or insurers; 5) broader healthcare-sector or S&P 500 movements that could sway sentiment. Therefore I need current (mid-February 2026) news and commentary on Cigna’s financial performance, outlook, and sector-level factors.

Search queries:
1. cigna group earnings feb 2026 (Google)
2. ci stock analyst rating February 2026 (Google News)
3. Summarize major February 2026 news impacting The Cigna Group stock, including earnings results, guidance, regulatory issues, or M&A rumors. (AskNews)